Zdrowie i gospodarka · 08/10/1999

FDA Releases Draft Guidance on Premarket Approval Applications for HCV Assays

The FDA has released a draft guidance document providing insights on the design and analysis of studies for in vitro diagnostic devices related to HCV diagnosis and monitoring, as part of the premarket approval application process.